Compare BLLN & CNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLLN | CNX |
|---|---|---|
| Founded | 2016 | 1860 |
| Country | United States | United States |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 4.8B |
| IPO Year | N/A | 1998 |
| Metric | BLLN | CNX |
|---|---|---|
| Price | $128.58 | $33.11 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 7 |
| Target Price | ★ $126.71 | $35.71 |
| AVG Volume (30 Days) | 706.5K | ★ 2.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 763.33 |
| EPS | N/A | ★ 2.18 |
| Revenue | N/A | ★ $2,239,134,000.00 |
| Revenue This Year | $46.29 | N/A |
| Revenue Next Year | $30.14 | $11.14 |
| P/E Ratio | ★ N/A | $14.98 |
| Revenue Growth | N/A | ★ 76.76 |
| 52 Week Low | $61.96 | $27.72 |
| 52 Week High | $138.70 | $43.62 |
| Indicator | BLLN | CNX |
|---|---|---|
| Relative Strength Index (RSI) | 63.97 | 47.31 |
| Support Level | $79.07 | $32.83 |
| Resistance Level | $138.70 | $34.33 |
| Average True Range (ATR) | 6.93 | 0.74 |
| MACD | -0.21 | 0.08 |
| Stochastic Oscillator | 91.96 | 55.18 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.